CA2183557A1 - Formule d'un aerosol medicamenteux contenant de la vitamine e - Google Patents

Formule d'un aerosol medicamenteux contenant de la vitamine e

Info

Publication number
CA2183557A1
CA2183557A1 CA002183557A CA2183557A CA2183557A1 CA 2183557 A1 CA2183557 A1 CA 2183557A1 CA 002183557 A CA002183557 A CA 002183557A CA 2183557 A CA2183557 A CA 2183557A CA 2183557 A1 CA2183557 A1 CA 2183557A1
Authority
CA
Canada
Prior art keywords
tocopherol
pharmaceutical composition
propellant
composition according
alpha tocopherol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002183557A
Other languages
English (en)
Inventor
Mou-Ying Fu Lu
Pramod K. Gupta
Akwete L. Adjei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2183557A1 publication Critical patent/CA2183557A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composition pharmaceutique pour aérosols comprenant: (a) un médicament, (b) un propulseur n'étant pas du fluorocarbone, (c) du tocophérol ou l'un de ses dérivés pharmacocompatibles, et procédé de préparation de ladite composition prévenant la formation d'agrégats de médicament sans recourir à des surfactants ou à des cosolvants
CA002183557A 1994-03-14 1995-03-02 Formule d'un aerosol medicamenteux contenant de la vitamine e Abandoned CA2183557A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21247294A 1994-03-14 1994-03-14
US08/212,472 1994-03-14
PCT/US1995/002764 WO1995024892A1 (fr) 1994-03-14 1995-03-02 Formule d'un aerosol medicamenteux contenant de la vitamine e

Publications (1)

Publication Number Publication Date
CA2183557A1 true CA2183557A1 (fr) 1995-09-21

Family

ID=22791169

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002183557A Abandoned CA2183557A1 (fr) 1994-03-14 1995-03-02 Formule d'un aerosol medicamenteux contenant de la vitamine e

Country Status (7)

Country Link
EP (1) EP0804157A1 (fr)
JP (1) JPH09510445A (fr)
KR (1) KR970701535A (fr)
AU (1) AU709783B2 (fr)
CA (1) CA2183557A1 (fr)
IL (1) IL112897A0 (fr)
WO (1) WO1995024892A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
EP0914143A1 (fr) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Formulation d'une solution d'aerosol medicinal de cyclosporine a
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1458360B1 (fr) 2001-12-19 2011-05-11 Novartis AG Administration pulmonaire d'aminoglycosides
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69231991T2 (de) * 1991-06-10 2002-04-04 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
ATE150296T1 (de) * 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten

Also Published As

Publication number Publication date
AU1980495A (en) 1995-10-03
AU709783B2 (en) 1999-09-09
JPH09510445A (ja) 1997-10-21
MX9604004A (es) 1997-12-31
KR970701535A (ko) 1997-04-12
EP0804157A1 (fr) 1997-11-05
WO1995024892A1 (fr) 1995-09-21
IL112897A0 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
EP0731688B1 (fr) Compositions medicamenteuses en aerosol pour utilisation avec des gaz propulseurs sans cfc
US5635159A (en) Aerosol drug formulations containing polyglycolyzed glycerides
AU749697B2 (en) Medicinal aerosol formulations
US5635161A (en) Aerosol drug formulations containing vegetable oils
US6461591B1 (en) Medical aerosol formulations
KR100275426B1 (ko) 가압 에어로솔 조성물
ES2358293T3 (es) Formulaciones de aerosol de diisobutirilapomorfina.
EP0617610B1 (fr) Formulations d'aerosol en suspension
ES2292713T3 (es) Formulaciones medicinales en aerosol.
EP1306082B1 (fr) Aérosols doseurs sous pression et compositions pharmaceutiques d'aérosol
AU3523199A (en) Pharmaceutical aerosol formulation
US6193954B1 (en) Formulations for pulmonary delivery of dopamine agonists
CA2183557A1 (fr) Formule d'un aerosol medicamenteux contenant de la vitamine e
US7186402B2 (en) Medicinal aerosol compositions with an amide and/or ester containing excipient compound
AU630669B2 (en) A nedocromil sodium aerosol composition containing flavouring and/or sweetening agents
MXPA96004004A (en) Formulations of aerosol drugs containing vitamin
KR0175164B1 (ko) 에어로졸 약물 제제

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued